ST
ANAC

Spot Trading’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Spot Trading’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,900
Closed -$208K – 4232
2016
Q1 		$208K Buy
3,900
+2,400
+160% +$177K ﹤0.01% 2189
2015
Q4 		$169K Sell
1,500
-300
-17% -$33K ﹤0.01% 2566
2015
Q3 		$212K Buy
1,800
+1,700
+1,700% +$222K ﹤0.01% 2661
2015
Q2 		$8K Sell
100
-400
-80% -$26.2K ﹤0.01% 3593
2015
Q1 		$29K Buy
+500
New +$21.2K ﹤0.01% 3430

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Spot Trading's ANAC Position: Q2 2016 in Review

Spot Trading sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 663 shares — an estimated $35K sold.

Spot Trading first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $1.63M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Spot Trading reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 663 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $35K.
  • Spot Trading first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
  • Spot Trading's ANACOR PHARMACEUTICALS INC COM position peaked at $1.63M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.